Does a glutamate receptor blocker (Caroverine) enhance haloperidol in the treatment of schizophrenia?
König
P
P
Landeskrankenhaus Rankweil, Rankweil, Austria.
Conca
A
A
Lugmayer
B
B
D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D004357:Drug Synergism; D018691:Excitatory Amino Acid Antagonists / Q000627:therapeutic use*; D005260:Female; D006220:Haloperidol / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D011569:Psychiatric Status Rating Scales; D011810:Quinoxalines / Q000627:therapeutic use*; D012189:Retrospective Studies; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology
D014150:Antipsychotic Agents; D018691:Excitatory Amino Acid Antagonists; D011810:Quinoxalines; D006220:Haloperidol; C000957:caroverine